Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Calliditas
Calliditas
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tarpeyo
Budesonide
2021-12-15
2026-2043
Chronic obstructive pulmonary disease
,
Asthma
,
Inflammatory bowel diseases
,
Allergic rhinitis perennial
,
Bronchial spasm
,
Hyperhidrosis
,
Iga glomerulonephritis
,
Esophageal diseases
,
Respiratory tract diseases
,
Peptic ulcer
,
Drug-induced abnormalities
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Budesonide
healthy volunteers/patients
,
respiratory aspiration
,
lung neoplasms
,
precancerous conditions
,
bronchiolitis obliterans syndrome
,
respiration disorders
,
bronchiolitis obliterans
,
bronchiolitis
,
dyspnea
,
colitis
,
exercise-induced asthma
,
eosinophilic esophagitis
,
esophagitis
,
allergic rhinitis seasonal
,
collagenous colitis
,
gastroesophageal reflux
,
peptic esophagitis
,
emergencies
,
recurrence
,
diarrhea
,
lymphocytic colitis
,
bronchial spasm
,
exercise-induced allergies
,
asthma
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
allergic rhinitis
,
rhinitis
,
cough-variant asthma
,
eosinophilia
,
pulmonary eosinophilia
,
inflammation
,
hypersensitivity
,
herpes zoster
,
chickenpox
,
allergic rhinitis perennial
,
emphysema
,
respiratory sounds
,
respiratory hypersensitivity
,
disease progression
,
cough
,
microscopic colitis
,
chronic disease
,
retrospective studies
SETANAXIB
biliary liver cirrhosis
,
cholangitis
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
diabetic nephropathies
,
albuminuria
,
type 2 diabetes mellitus
,
diabetes mellitus
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
hereditary nephritis
Bevifimod
primary ovarian insufficiency
,
female infertility
,
ovulation induction
,
infertility
,
asthma
,
fertilization in vitro
,
dysmenorrhea
,
contraception
,
proteinuria
,
cardiovascular diseases
,
myocardial infarction
,
ischemia
,
acute coronary syndrome
,
myocardial ischemia
,
angina pectoris
,
psoriasis
,
ovarian hyperstimulation syndrome
,
pregnancy
,
congenital abnormalities
,
hemorrhage
,
hypercholesterolemia
,
dyslipidemias
Corticorelin
chronic kidney failure
,
kidney diseases
,
renal insufficiency
,
fabry disease
Globulin, immune
non-small-cell lung carcinoma
,
uterine neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
squamous cell carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
GKT137831
biliary liver cirrhosis
,
cholangitis
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
diabetic nephropathies
,
albuminuria
,
type 2 diabetes mellitus
,
diabetes mellitus
,
hereditary nephritis
Mk3475
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
endometrial neoplasms
Nefecon
kidney diseases
,
iga glomerulonephritis
,
chronic kidney failure
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use